| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 129.78B | 124.41B | 93.25B | 94.52B | 67.00B | 50.80B |
| Gross Profit | 50.56B | 49.62B | 35.26B | 34.81B | 22.64B | 14.72B |
| EBITDA | 34.28B | 37.20B | 26.94B | 32.38B | 20.05B | 10.28B |
| Net Income | 18.66B | 23.63B | 19.58B | 21.38B | 12.82B | 6.47B |
Balance Sheet | ||||||
| Total Assets | 177.93B | 187.74B | 156.14B | 126.48B | 88.29B | 59.53B |
| Cash, Cash Equivalents and Short-Term Investments | 60.95B | 62.99B | 37.95B | 28.29B | 23.63B | 16.83B |
| Total Debt | 26.65B | 31.61B | 34.51B | 32.82B | 20.89B | 16.77B |
| Total Liabilities | 51.43B | 59.02B | 56.59B | 51.69B | 38.07B | 24.93B |
| Stockholders Equity | 116.67B | 117.90B | 92.30B | 68.31B | 45.43B | 30.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 34.84B | 14.33B | -6.43B | 975.95M | 5.84B |
| Operating Cash Flow | 0.00 | 36.79B | 15.54B | -1.92B | 3.02B | 8.16B |
| Investing Cash Flow | 0.00 | -6.46B | -5.91B | -5.15B | -916.92M | -2.66B |
| Financing Cash Flow | 0.00 | -9.16B | -792.00M | 10.74B | 3.58B | -1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥1.81T | 15.60 | 21.73% | 2.29% | 11.29% | 11.38% | |
77 Outperform | ¥488.81B | 13.81 | ― | 0.79% | 15.38% | -26.84% | |
75 Outperform | $7.55T | 35.55 | 25.78% | 0.79% | 13.45% | 20.37% | |
73 Outperform | ¥18.02T | 33.18 | 26.01% | 1.79% | 16.74% | 16.03% | |
71 Outperform | ¥417.91B | 22.63 | ― | 1.02% | 29.60% | 24.39% | |
62 Neutral | ¥1.29T | 44.15 | ― | 0.73% | 10.98% | 6.51% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
Rorze Corporation has disclosed that a U.S. federal jury in the Northern District of California returned a verdict against the company and its U.S. subsidiary in a patent infringement lawsuit brought by Kawasaki Heavy Industries, awarding provisional damages of 48 million dollars. The dispute centers on alleged infringement of Kawasaki’s U.S. patent rights, which Rorze has consistently argued are neither infringed nor valid, and the company is now evaluating the financial impact while preparing to pursue post-trial motions and an appeal, signaling ongoing legal and earnings uncertainty for shareholders and business partners.
Management emphasized that the verdict is not final and that all lawful avenues will be used to seek review and possible reversal, a stance that could extend the litigation timeline and delay clarity on ultimate liability. Until the legal process concludes and the financial effects are quantified, the ruling introduces additional risk to Rorze’s balance sheet and may influence its strategic flexibility, although the company has committed to making further disclosures if the situation triggers material impacts requiring timely announcement.
The most recent analyst rating on (JP:6323) stock is a Buy with a Yen3318.00 price target. To see the full list of analyst forecasts on Rorze Corporation stock, see the JP:6323 Stock Forecast page.
Rorze Corporation reported consolidated net sales of ¥94.5 billion for the nine months ended November 30, 2025, a 5.9% increase year on year, while operating profit fell 8.1% to ¥23.5 billion and profit attributable to owners of parent declined 11.4% to ¥17.5 billion, resulting in lower earnings per share despite higher revenue. The balance sheet strengthened as total assets stood at ¥182.7 billion and the equity-to-asset ratio improved to 68.2%, and the company confirmed its full-year forecast calling for modest 3.0% sales growth and slight profit declines, while maintaining its annual dividend plan of ¥17 per share, signaling stable shareholder returns but a more subdued earnings environment compared with the previous strong year.
The most recent analyst rating on (JP:6323) stock is a Buy with a Yen2888.00 price target. To see the full list of analyst forecasts on Rorze Corporation stock, see the JP:6323 Stock Forecast page.